The standard of care in medicine is not a static rule but a dynamic concept that evolves with scientific discovery. Landmark clinical trials continuously challenge existing practices, and when a new therapy demonstrates superior efficacy or a significant advantage, it can redefine the standard of care. For PharmD students, understanding this process, as exemplified by … Read more
Harnessing targeted therapies represents a paradigm shift in oncology, moving beyond traditional chemotherapy to treatments that exploit specific vulnerabilities of cancer cells. Drugs like inotuzumab ozogamicin and blinatumomab, used in acute lymphoblastic leukemia, exemplify this approach. For PharmD students, a deep dive into the mechanisms of these advanced therapies—from antibody-drug conjugates to Bi-specific T-cell Engagers—is … Read more
Lymphomas are a diverse group of blood cancers that originate in the lymphatic system. Broadly classified into Hodgkin and Non-Hodgkin lymphoma, their treatment has seen remarkable evolution, with targeted immunotherapies now joining traditional chemotherapy as cornerstones of care. For PharmD students, a solid understanding of lymphoma classification, treatment regimens, and the management of therapy-related toxicities … Read more
Improving patient safety is a fundamental tenet of pharmacy practice. It extends beyond accurate dispensing to encompass systems-level thinking, effective communication, and a commitment to a “culture of safety.” For PharmD students, mastering concepts like medication reconciliation, root cause analysis, and quality improvement is essential for minimizing medication errors, preventing adverse drug events, and contributing … Read more
In modern oncology, patients often have multiple effective treatment options available. This raises a critical clinical question: what is the best order in which to use them? Determining the optimal sequence of therapies is a complex challenge addressed by sophisticated clinical trials. For PharmD students, understanding how these trials are designed and how to interpret … Read more
Not all clinical trials are designed to prove a new drug is better than the standard of care. Non-inferiority trials play a crucial role in drug development by aiming to demonstrate that a new therapy is “not unacceptably worse” than an existing active control. For PharmD students, understanding the unique design, statistical analysis, and interpretation … Read more
Basket trials represent a paradigm shift in precision oncology, moving beyond organ-specific treatment to a “tumor-agnostic” approach. These contemporary trial designs evaluate a single targeted therapy across multiple diseases that all share a common molecular driver. For PharmD students, understanding the basket trial design is crucial for interpreting the evidence that leads to landmark approvals … Read more
As medicine shifts towards a precision oncology approach, clinical trial designs must also evolve. The umbrella trial is an innovative and efficient “master protocol” design that moves away from the one-size-fits-all model. For PharmD students, understanding contemporary trial designs like the umbrella trial is essential for interpreting modern clinical literature and appreciating how targeted therapies … Read more
In clinical trials, endpoints are used to measure the effects of a therapy. While a true clinical endpoint directly measures how a patient feels, functions, or survives, researchers often use surrogate endpoints as a substitute. For PharmD students, the ability to critically evaluate clinical literature requires a deep understanding of the validity, application, and limitations … Read more
